EGFR Resisters Partners With LUNGevity to Issue RFA for Research Into EGFR-Positive Lung Cancer
January 26, 2023
January 26, 2023
WASHINGTON, Jan. 26 -- The LUNGevity Foundation issued the following news release on Jan. 25, 2023:
LUNGevity Foundation is honored to announce its second research partnership with the EGFR Resisters in issuing a Request for Application (RFA) for high-impact research focused on EGFR-positive lung cancer. The EGFR Resisters is a powerful patient-led community advocating for improved treatment options for patients with EGFR-positive lung cancer. This collaboration aims to transform th . . .
LUNGevity Foundation is honored to announce its second research partnership with the EGFR Resisters in issuing a Request for Application (RFA) for high-impact research focused on EGFR-positive lung cancer. The EGFR Resisters is a powerful patient-led community advocating for improved treatment options for patients with EGFR-positive lung cancer. This collaboration aims to transform th . . .